Armet/Manf and Creld2 are components of a specialized ER stress response provoked by inappropriate formation of disulphide bonds: Implications for genetic skeletal diseases

Human Molecular Genetics

Volumn 22, Issue 25, 2013, Pages 5262-5275

  Hartley, Claire L ^a   Edwards, Sarah ^a   Mullan, Lorna ^a   Bell, Peter A ^a   Fresquet, Maryline ^a   Boot Handford, Raymond P ^a   Briggs, Michael D ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; ARMET PROTEIN; COLLAGEN TYPE 10; CRELD2 PROTEIN; CYSTEINE; GLUCOSE REGULATED PROTEIN 78; GLUCOSE REGULATED PROTEIN 94; MATRILIN 3; MESSENGER RNA; PROTEIN DISULFIDE ISOMERASE; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE DISEASE; CARTILAGE CELL; CELL STRAIN HEK293; CHONDRODYSPLASIA; CONTROLLED STUDY; DISULFIDE BOND; ENDOPLASMIC RETICULUM STRESS; GENOTYPE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SECRETION; UPREGULATION; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; CELL ADHESION MOLECULES; CHONDROCYTES; COLLAGEN TYPE X; DISEASE MODELS, ANIMAL; ENDOPLASMIC RETICULUM; ENDOPLASMIC RETICULUM STRESS; EXTRACELLULAR MATRIX PROTEINS; GENE EXPRESSION REGULATION; HUMANS; MATRILIN PROTEINS; MICE; NERVE GROWTH FACTORS; OSTEOCHONDRODYSPLASIAS;

EID: 84888798060     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddt383     Document Type: Article

References (56)

1. Warman, M.L., Cormier-Daire, V., Hall, C., Krakow, D., Lachman, R., LeMerrer, M., Mortier, G., Mundlos, S., Nishimura, G., Rimoin, D.L. et al. (2011) Nosology and classification of genetic skeletal disorders: 2010 revision. Am. J. Med. Genet. A, 155A, 943-968.
2. Jackson, G.C., Mittaz-Crettol, L., Taylor, J.A., Mortier, G.R., Spranger, J., Zabel, B., Le Merrer, M., Cormier-Daire, V., Hall, C.M., Offiah, A. et al. (2012) Pseudoachondroplasia and multiple epiphyseal dysplasia: a 7-year comprehensive analysis of the known disease genes identify novel and recurrent mutations and provides an accurate assessment of their relative contribution. Hum. Mutat., 33, 144-157.
3. McIntosh, I., Abbott, M.H., Warman, M.L., Olsen, B.R. and Francomano, C.A. (1994) Additional mutations of type X collagen confirm COL10A1 as the Schmid metaphyseal chondrodysplasia locus.Hum. Mol. Genet., 3, 303-307.
4. Bateman, J.F., Boot-Handford, R.P. and Lamande, S.R. (2009) Genetic diseases of connective tissues: cellular and extracellular effects of ECM mutations. Nat. Rev. Genet., 10, 173-183.
5. Boot-Handford, R.P. and Briggs, M.D. (2009) The unfolded protein response and its relevance to connective tissue diseases. Cell Tissue Res., 339, 197-211.
6. Kaufman, R.J. (2002) Orchestrating the unfolded protein response in health and disease. J. Clin. Invest., 110, 1389-1398.
7. Rutkowski, D.T. and Kaufman, R.J. (2004) A trip to the ER: coping with stress. Trends Cell Biol., 14, 20-28.
8. Kim, P.S., Kwon, O.Y. and Arvan, P. (1996) An endoplasmic reticulum storage disease causing congenital goiter with hypothyroidism. J. Cell Biol., 133, 517-527.
9. Ron, D. and Walter, P. (2007) Signal integration in the endoplasmic reticulum unfolded protein response. Nat. Rev. Mol. Cell Biol., 8, 519-529.
10. Leighton, M.P., Nundlall, S., Starborg, T., Meadows, R.S., Suleman, F., Knowles, L., Wagener, R., Thornton, D.J., Kadler, K.E., Boot-Handford, R.P. et al. (2007) Decreased chondrocyte proliferation and dysregulated apoptosis in the cartilage growth plate are key features of a murine model of epiphyseal dysplasia caused by a matn3 mutation. Hum. Mol. Genet., 16, 1728-1741.
11. Pirog-Garcia, K.A., Meadows, R.S., Knowles, L., Heinegard, D., Thornton, D.J., Kadler, K.E., Boot-Handford, R.P. and Briggs, M.D. (2007) Reduced cell proliferation and increased apoptosis are significant pathological mechanismsin a murine model of mild pseudoachondroplasia resulting from a mutation in the C-terminal domain ofCOMP.Hum.Mol. Genet., 16, 2072-2088.
12. Nundlall, S., Rajpar, M.H., Bell, P.A., Clowes, C., Zeeff, L.A., Gardner, B., Thornton, D.J., Boot-Handford, R.P. and Briggs, M.D. (2010) An unfolded protein response is the initial cellular response to the expression of mutant matrilin-3 in a mouse model of multiple epiphyseal dysplasia. Cell Stress Chaperones, 15, 835-849.
13. Suleman, F., Gualeni, B., Gregson, H.J., Leighton, M.P., Pirog, K.A., Edwards, S., Holden, P., Boot-Handford, R.P. and Briggs, M.D. (2012) A novel form of chondrocyte stress is triggered by a COMP mutation causing pseudoachondroplasia. Hum. Mutat., 33, 218-231.
14. Rajpar, M.H., McDermott, B., Kung, L., Eardley, R., Knowles, L., Heeran, M., Thornton, D.J., Wilson, R., Bateman, J.F., Poulsom, R. et al. (2009) Targeted induction of endoplasmic reticulum stress induces cartilage pathology. PLoS Genet., 5, e1000691.
15. Tsang, K.Y., Chan, D., Cheslett, D., Chan, W.C., So, C.L., Melhado, I.G., Chan, T.W., Kwan, K.M., Hunziker, E.B., Yamada, Y. et al. (2007) Surviving endoplasmic reticulum stress is coupled to altered chondrocyte differentiation and function. PLoS Biol., 5, e44.
16. Ho, M.S., Tsang, K.Y., Lo, R.L., Susic, M., Makitie, O., Chan, T.W., Ng, V.C., Sillence, D.O., Boot-Handford, R.P., Gibson, G. et al. (2007) COL10A1 nonsense and frame-shift mutations have a gain-of-function effect on the growth plate in human and mouse metaphyseal chondrodysplasia type Schmid. Hum. Mol. Genet., 16, 1201-1215.
17. Klatt, A.R., Becker, A.K., Neacsu, C.D., Paulsson, M. and Wagener, R. (2011) The matrilins: modulators of extracellular matrix assembly. Int. J. Biochem. Cell Biol., 43, 320-330.
18. Chapman, K.L., Mortier, G.R., Chapman, K., Loughlin, J., Grant, M.E. and Briggs, M.D. (2001) Mutations in the region encoding the von Willebrand factor A domain of matrilin-3 are associated with multiple epiphyseal dysplasia. Nat. Genet., 28, 393-396.
19. Jackson, G.C., Barker, F.S., Jakkula, E., Czarny-Ratajczak, M., Makitie, O., Cole, W.G., Wright, M.J., Smithson, S.F., Suri, M., Rogala, P. et al. (2004) Missense mutations in the beta strands of the single A-domain of matrilin-3 result in multiple epiphyseal dysplasia. J. Med. Genet., 41, 52-59.
20. Mabuchi, A., Haga, N., Maeda, K., Nakashima, E., Manabe, N., Hiraoka, H., Kitoh, H., Kosaki, R., Nishimura, G., Ohashi, H. et al. (2004) Novel and recurrent mutations clustered in the von Willebrand factor A domain of MATN3 in multiple epiphyseal dysplasia. Hum. Mutat., 24, 439-440.
21. Fresquet, M., Jackson, G.C., Loughlin, J. and Briggs, M.D. (2008) Novel mutations in exon 2 ofMATN3affect residues within the alpha-helices of the A-domain and can result in the intracellular retention of mutant matrilin-3. Hum. Mutat., 29, 330.
22. Ellgaard, L. and Ruddock, L.W. (2005) The human protein disulphide isomerase family: substrate interactions and functional properties. EMBO Rep., 6, 28-32.
23. Hatahet, F. and Ruddock, L.W. (2007) Substrate recognition by the protein disulfide isomerases. FEBS J., 274, 5223-5234.
24. Ferrari, D.M. and Soling, H.D. (1999) The protein disulphide-isomerase family: unravelling a string of folds. Biochem. J., 339, 1-10.
25. Oh-hashi, K., Koga, H., Ikeda, S., Shimada, K., Hirata, Y. and Kiuchi, K. (2009) Creld2 is a novel endoplasmic reticulum stress-inducible gene. Biochem. Biophys. Res. Commun., 387, 504-510.
26. Apostolou, A., Shen, Y., Liang, Y., Luo, J. and Fang, S. (2008) Armet, a UPR-upregulated protein, inhibits cell proliferation and ER stress-induced cell death. Exp. Cell Res., 314, 2454-2467.
27. Mizobuchi, N., Hoseki, J., Kubota, H., Toyokuni, S., Nozaki, J., Naitoh, M., Koizumi,A. and Nagata, K. (2007) Armet is a solubleERprotein induced by the unfolded protein response via ERSE-II element. Cell Struct. Funct., 32, 41-50.
28. Airavaara, M., Shen, H., Kuo, C.C., Peranen, J., Saarma, M., Hoffer, B. and Wang, Y. (2009) Mesencephalic astrocyte-derived neurotrophic factor reduces ischemic brain injury and promotes behavioral recovery in rats. J. Comp. Neurol., 515, 116-124.
29. Ortiz, J.A., Castillo, M., del Toro, E.D., Mulet, J., Gerber, S., Valor, L.M., Sala, S., Sala, F., Gutierrez, L.M. and Criado, M. (2005) The cysteine-rich with EGF-like domains 2 (Creld2) protein interacts with the large cytoplasmic domain of human neuronal nicotinic acetylcholine receptor alpha4 and beta2 subunits. J Neurochem, 95, 1585-1596.
30. Cotterill, S.L., Jackson, G.C., Leighton, M.P., Wagener, R., Makitie, O., Cole, W.G. and Briggs, M.D. (2005) Multiple epiphyseal dysplasia mutations in MATN3 cause misfolding of the A-domain and prevent secretion of mutant matrilin-3. Hum. Mutat., 26, 557-565.
31. Cameron, T.L., Bell, K.M., Tatarczuch, L., Mackie, E.J., Rajpar, M.H., McDermott, B.T., Boot-Handford, R.P. and Bateman, J.F. (2011) Transcriptional profiling of chondrodysplasia growth plate cartilage reveals adaptive ER-stress networks that allow survival but disrupt hypertrophy. PLoS One, 6, e24600.
32. Zhao, L., Rosales, C., Seburn, K., Ron, D. and Ackerman, S.L. (2010) Alteration of the unfolded protein response modifies neurodegeneration in a mouse model of Marinesco-Sjogren syndrome. Hum. Mol. Genet., 19, 25-35.
33. Lindholm, P. and Saarma, M. (2010) Novel CDNF/MANF family of neurotrophic factors. Dev. Neurobiol., 70, 360-371.
34. Jessop, C.E., Chakravarthi, S., Garbi, N., Hammerling, G.J., Lovell, S. and Bulleid, N.J. (2007) ERp57 is essential for efficient folding of glycoproteins sharing common structural domains. EMBO J., 26, 28-40.
35. Bell, P.A., Pirog, K.A., Fresquet, M., Thornton, D.J., Boot-Handford, R.P. and Briggs, M.D. (2012) Loss of matrilin 1 does not exacerbate the skeletal phenotype in a mouse model of multiple epiphyseal dysplasia caused by a Matn3 V194D mutation. Arthritis Rheum., 64, 1529-1539.
36. Jansen, G., Maattanen, P., Denisov, A.Y., Scarffe, L., Schade, B., Balghi, H., Dejgaard, K., Chen, L.Y., Muller, W.J., Gehring, K. et al. (2012) An interaction map of endoplasmic reticulum chaperones and foldases. Mol. Cell Proteomics, 11, 710-723.
37. Pfeffer, S.R. (2007) Unsolved mysteries in membrane traffic. Annu. Rev. Biochem., 76, 629-645.
38. Raykhel, I., Alanen, H., Salo, K., Jurvansuu, J., Nguyen, V.D., Latva-Ranta, M. and Ruddock, L. (2007) A molecular specificity code for the three mammalian KDEL receptors. J. Cell Biol., 179, 1193-1204.
39. Oh-Hashi, K., Tanaka, K., Koga, H., Hirata, Y. and Kiuchi, K. (2012) Intracellular trafficking and secretion of mouse mesencephalic astrocyte-derived neurotrophic factor. Mol. Cell Biochem., 363, 35-41.
40. Glembotski, C.C. (2011) Functions for the cardiomyokine, MANF, in cardioprotection, hypertrophy and heart failure. J. Mol. Cell Cardiol., 51, 512-517.
41. Llewellyn, D.H., Roderick, H.L. and Rose, S. (1997) KDEL receptor expression is not coordinatedly up-regulated with ER stress-induced reticuloplasmin expression in HeLa cells. Biochem. Biophys. Res. Commun., 240, 36-40.
42. Lampe, A.K. and Bushby, K.M. (2005) Collagen VI related muscle disorders. J. Med. Genet., 42, 673-685.
43. Mellerio, J.E., Eady, R.A., Atherton, D.J., Lake, B.D. and McGrath, J.A. (1998) E210 K mutation in the gene encoding the beta3 chain of laminin-5 (LAMB3) is predictive of a phenotype of generalized atrophic benign epidermolysis bullosa. Br. J. Dermatol., 139, 325-331.
44. Tooley, L.D., Zamurs, L.K., Beecher, N., Baker, N.L., Peat, R.A., Adams, N.E., Bateman, J.F., North, K.N., Baldock, C. and Lamande, S.R. (2010) Collagen VI microfibril formation is abolished by an {alpha}2(VI) von Willebrand factor type A domain mutation in a patient with Ullrich congenital muscular dystrophy. J. Biol. Chem., 285, 33567-33576.
45. Baker, N.L., Morgelin, M., Pace, R.A., Peat, R.A., Adams, N.E., Gardner, R.J., Rowland, L.P., Miller, G., De Jonghe, P., Ceulemans, B. et al. (2007) Molecular consequences of dominant Bethlem myopathy collagen VI mutations. Ann. Neurol., 62, 390-405.
46. Wang, J., Takeuchi, T., Tanaka, S., Kubo, S.K., Kayo, T., Lu, D., Takata, K., Koizumi, A. and Izumi, T. (1999) A mutation in the insulin 2 gene induces diabetes with severe pancreatic beta-cell dysfunction in the Mody mouse. J. Clin. Invest., 103, 27-37.
47. Hartley, T., Siva, M., Lai, E., Teodoro, T., Zhang, L. and Volchuk, A. (2010) Endoplasmic reticulum stress response in an INS-1 pancreatic beta-cell line with inducible expression of a folding-deficient proinsulin. BMC Cell Biol., 11, 59.
48. Wilson, R., Freddi, S., Chan, D., Cheah, K.S. and Bateman, J.F. (2005) Misfolding of collagen X chains harboring Schmid metaphyseal chondrodysplasia mutations results in aberrant disulfide bond formation, intracellular retention, and activation of the unfolded protein response. J. Biol. Chem., 280, 15544-15552.
49. Wilson, R., Freddi, S. and Bateman, J.F. (2002) CollagenXchains harboring Schmid metaphyseal chondrodysplasia NC1 domain mutations are selectively retained and degraded in stably transfected cells. J. Biol. Chem., 277, 12516-12524.
50. Dinser, R., Zaucke, F., Kreppel, F., Hultenby, K., Kochanek, S., Paulsson,M. and Maurer, P. (2002) Pseudoachondroplasia is caused through both intraand extracellular pathogenic pathways. J. Clin. Invest., 110, 505-513.
51. Hashimoto, Y., Tomiyama, T., Yamano, Y. and Mori, H. (2003) Mutation (D472Y) in the type 3 repeat domain of cartilage oligomeric matrix protein affects its early vesicle trafficking in endoplasmic reticulum and induces apoptosis. Am. J. Pathol., 163, 101-110.
52. Schmitz, M., Becker, A., Schmitz, A., Weirich, C., Paulsson, M., Zaucke, F. and Dinser, R. (2006) Disruption of extracellular matrix structure may cause pseudoachondroplasia phenotypes in the absence of impaired cartilage oligomeric matrix protein secretion. J. Biol. Chem., 281, 32587-32595.
53. Whittaker, C.A. and Hynes, R.O. (2002) Distribution and evolution of von willebrand/integrin a domains: widely dispersed domains with roles in cell adhesion and elsewhere. Mol. Biol. Cell, 13, 3369-3387.
54. Hanrahan, J.W., Sampson, H.M. and Thomas, D.Y. (2013) Novel pharmacological strategies to treat cystic fibrosis. Trends Pharmacol. Sci., 34, 119-125.
55. Sampson, H.M., Lam, H., Chen, P.C., Zhang, D., Mottillo, C., Mirza, M., Qasim, K., Shrier, A., Shyng, S.L., Hanrahan, J.W. et al. (2013) Compounds that correct F508del-CFTR trafficking can also correct other protein trafficking diseases: an in vitro study using cell lines. Orphanet J. Rare Dis., 8, 11.
56. Xu, S., Butkevich, A.N., Yamada, R., Zhou, Y., Debnath, B., Duncan, R., Zandi, E., Petasis, N.A. and Neamati, N. (2012) Discovery of an orally active small-molecule irreversible inhibitor of protein disulfide isomerase for ovarian cancer treatment. Proc. Natl Acad. Sci. USA, 109, 16348-16353.